Guidelines for vismodegib in the management of periocular basal cell carcinoma

The management of advanced basal cell carcinoma (BCC) in the periocular region remains a clinical challenge. Vismodegib (ErivedgeTM) has been approved in 2013 by Health Canada for adult patients with “histologically confirmed metastatic BCC or locally advanced BCC inappropriate for surgery or radiat...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Canadian journal of ophthalmology 2020-06, Vol.55 (3), p.245-252
Hauptverfasser:	Hussain, Ahsen, Tucker, Nancy, DeAngelis, Dan D., Yin, Vivian T., Ing, Edsel, Arthurs, Bryan, Gill, Harmeet S., Hardy, Isabelle, Hurwitz, Jeff, Kratky, Vladimir, Maleki, Babak, Nijhawan, Navdeep, Oestreicher, James, Zafar, Aftab
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!